Health
Open
72 trades
Which pharma company leads obesity-drug revenue in 2026?
$6,726.58 vol.
Mar 3, 2027
Health
Eli Lilly
26c
-8.8 pts
Novo Nordisk
25c
-6.3 pts
Outcomes
Eli Lilly
Novo Nordisk
Pfizer
Other
Recent Trades
| User | Action | Outcome | Shares | Amount | When |
|---|---|---|---|---|---|
| No activity yet. | |||||
How It Resolves
Practice health market tracking the real-world outcome for "Which pharma company leads obesity-drug revenue in 2026?" with paper-money positions and LMSR pricing.
Resolves to the listed outcome that best matches the final official result for "Which pharma company leads obesity-drug revenue in 2026?", using Company Earnings as the primary source.
Trade
Sign in or create an account to trade, redeem complete sets, and track your paper portfolio.